In the past year, the optical products company has managed to quietly settle almost 600 lawsuits involving claims of fungal-infections, while dozens of individual claims are still waiting to be heard.

- Besivance Adds to Bausch & Lomb's Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) - MADISON, N.J., May 29 /PRNewswire/ -- Bausch & Lomb, a world leader in eye health, today announced that the U.S.

Bausch & Lomb Inc. failed to formally report nearly three dozen foreign cases of fungal eye infections later linked to one of its contact lens solutions, according to a federal warning letter.

By Julie Steenhuysen CHICAGO (Reuters) - Bausch & Lomb Inc.'s global recall of a popular contact lens solution in May appears to have stopped the spread of a serious eye infection but U.S. scientists still do not know what caused the outbreak, according to a study released on Tuesday.

By Julie Steenhuysen CHICAGO (Reuters) - Bausch & Lomb Inc.'s global recall of a popular contact lens solution in May appears to have stopped the spread of a serious eye infection but U.S. scientists still do not know what caused the outbreak, according to a study released on Tuesday.